KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Long-Term Deferred Tax (2016)

Neogenomics' Long-Term Deferred Tax history spans 3 years, with the latest figure at $6.5 million for Q4 2016.

  • For Q4 2016, Long-Term Deferred Tax rose 120.06% year-over-year to $6.5 million; the TTM value through Dec 2016 reached $6.5 million, up 120.06%, while the annual FY2016 figure was $6.5 million, 120.06% up from the prior year.
  • Long-Term Deferred Tax reached $6.5 million in Q4 2016 per NEO's latest filing, up from -$32.4 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $6.5 million in Q4 2016 to a low of -$32.4 million in Q4 2015.
  • Average Long-Term Deferred Tax over 3 years is -$8.5 million, with a median of $320000.0 recorded in 2014.
  • Peak YoY movement for Long-Term Deferred Tax: plummeted 10227.81% in 2015, then soared 120.06% in 2016.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $320000.0 in 2014, then tumbled by 10227.81% to -$32.4 million in 2015, then surged by 120.06% to $6.5 million in 2016.
  • Per Business Quant, the three most recent readings for NEO's Long-Term Deferred Tax are $6.5 million (Q4 2016), -$32.4 million (Q4 2015), and $320000.0 (Q4 2014).